Hepatic artery infusion chemotherapy (HAIC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hepatic artery infusion chemotherapy (HAIC), covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03) [Phase 2]